The open index of psychedelic research

Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis.

Lunsky I, Gutierrez G, Wang X +8

Structural imaging predictors of ketamine response in treatment-resistant depression: a machine learning approach.

Bryant L, Alexander L, Mena S +12

Induction agents for emergency tracheal intubation in critically ill adults: a systematic review and network meta-analysis.

Zampieri FG, Schmidt RC, Besen BAMP +5

Case Report: Oral glutamatergic augmentation for trauma-related disorders with fluoxetine-/bupropion-potentiated dextromethorphan ± piracetam: a four-patient case series.

Cheung N

Pre-registered hERG QSAR Predictions for Coronaridine and Oxa-noribogaine

Associations between psychedelic use and migraine history in Swedish twins.

Simonsson O, Sun S, Wesseldijk LW +3

Effect of Subanesthetic Doses of Esketamine on Early Postoperative Pain Sensitivity in Patients Undergoing Salpingectomy: A Randomized Clinical Trial.

Wu Y, Wu H, Dong J +11

Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review

Walters CK, Chetty S, Rants’o TA +2

LSD persistently disrupts affective pain processing

Plotkin J, Zhu E, Druart M +7

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

Colcott J, Guerin AA, Carter O +10

Psychedelics and Wellbeing in Autistic Populations: A Scoping Review of Literature Since the “Psychedelic Renaissance”

Psychedelics and Wellbeing in Autistic Populations: A Scoping Review of Literature Since the “Psychedelic Renaissance”

Efficacy and safety of N-methyl-d-aspartate receptor antagonists for preventing acute postoperative pain: A systematic review and network meta-analysis of randomized controlled trials.

Zhou J, Wen Y, Xu S +3

Intoxication with nutmeg: A case presentation and analysis of Swiss poisons information center (Tox Info Suisse) enquiries 2014-2023.

Bleisch A, Späni S, Schumann R +3

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration.

Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M +2

Ketamine and Esketamine in Neurology and Psychiatry: An Overview.

Honnekeri AS

Setting, context and the regulatory atmospheres of psychedelic medicine.

Gearin AK, Cohen IG, Garcia-Romeu A

Exploring new avenues: Psychedelic-assisted therapy for young people.

Vamvakopoulou IA, Nicholls D, Nutt DJ +1

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review.

Stojanović T, Nilsson KW, Fredriksson R +2

Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT

Tarailis P, Griskova-Bulanova I

Cognitive effects of intravenous Ketamine in treatment-resistant depression: A systematic review.

Chavigny LA, Desbeaumes Jodoin V, Garel N +4

S-ketamine, suggestibility, and spontaneous thought: a double-blind randomized crossover EEG study extending the ESKOP protocol

S-ketamine, suggestibility, and spontaneous thought: a double-blind randomized crossover EEG study extending the ESKOP protocol